Introduction: Imagery rescripting (ImRs) is a psychotherapeutic intervention targeting aversive memories. During the three-phase intervention, patients reexperience their aversive memory (phase 1), observe the scene from their adult perspective, and intervene to help their former selves (phase 2), and reexperience it again with the positive changes (phase 3). Previous studies have rarely investigated emotional and regulatory processes taking place during the intervention. Objective: This randomized controlled trial investigated self-reported affective and physiological responses during ImRs. Methods: Seventy-seven patients with social anxiety disorder (SAD) were randomly assigned to a single session of ImRs or a control intervention (recall and discussion of the memory) targeting an aversive social memory. Heart rate (HR) and heart rate variability (HRV) were assessed during and post hoc ratings of positive and negative feelings after baseline and the intervention phases. Results: Relative to the control intervention, ImRs resulted in an initial increase in negative feelings from baseline to phase 1 and a following larger (phase 1 to phase 2) and more stable (phase 2 to phase 3) decrease in negative feelings/increase in positive feelings. On the physiological level, during ImRs compared to the control intervention, mean HR was significantly higher during phase 1 and HRV during phase 3, each compared to baseline. Conclusions: These results provide further information about the specific sequence of emotional responses on different response levels during ImRs, being consistent with known theories of emotional processing and supposed mechanisms of ImRs.

The experience of distorted self-images, frequently associated with past aversive social experiences, is a common feature of social anxiety disorder (SAD) [1‒3]. Changing the memory representation of these experiences to alter mental images has become a goal of psychotherapeutic interventions, such as imagery rescripting (ImRs) [4‒6]. During ImRs, patients reexperience their aversive memory from their child perspective (phase 1), then observe and intervene from their adult perspective to support and meet the needs of their child self (phase 2), and finally, reexperience the scene again from their child perspective observing the actions of their adult self (phase 3) [5, 6].

From a learning theory perspective, the intervention is assumed to modify the original or create a competing representation of the aversive event in memory, while cognitive perspectives consider changes in the meaning of the aversive memory and related schemata to be a central mechanism [4, 7, 8]. Both theories are underpinned by findings of ImRs resulting in stronger positive affective responses during aversive memory recall after ImRs, as well as positive changes in memory appraisals, associated core beliefs, and/or perceived mastery [9‒16].

The use of imagery in psychotherapeutic interventions has gained increasing attention, as imagery compared to verbal processing results in a stronger emotional activation [17], which in turn is theorized to be a necessary condition for emotional change (“activation of fear structure” [18]). In patients with SAD, ImRs/imagery-enhanced cognitive behavioral therapy resulted in a stronger modulation of physiological responses associated with emotional activation (e.g., attenuated heart rate [HR] during baseline [19] or increased heart rate variability [HRV] during a subsequent speech task [20]). HRV, reflecting the variation of intervals between heartbeats, represents the interplay of sympathetic (HR increases) and parasympathetic activity (HR decreases) [21, 22]. One prominent indicator of HRV, the root mean square of successive differences (RMSSD), predominantly indicates parasympathetic activation (while frequency-domain HRV parameters also reflect sympathetic activity) [23]. The flexible interaction of both branches of the autonomic nervous system is of particular importance for an adaptive physiological response to environmental demands and is, as such, also closely linked to the ability to regulate one’s emotions [22]. Accordingly, previous studies have demonstrated that increases in HRV are associated with emotion regulation [24], as well as with changes in activity of brain regions associated with emotion regulation processes [25]. Therefore, the abovementioned increased HRV during a speech task following ImRs probably indicates increased regulatory control over autonomic responses [20]. Promoting such regulatory processes might be crucially important, as previous research demonstrated higher HR during fearful imagery in SAD [26‒28], indicating increased sympathetic/decreased parasympathetic activity [21, 29, 30].

While previous findings provide valuable insights into affective, cognitive, and physiological changes as a result of ImRs, processes that occur during the intervention have rarely been investigated. One recent study [31], however, showed a large increase in positive affective valence from phase 1 to phase 2 of ImRs in patients with SAD, indicating that ImRs supports patients in adaptively regulating their emotions during the intervention. According to Gross, emotion regulation comprises “all processes by which individuals influence which emotions they have, when they have them, and how they experience and express these emotions” ([32], p. 275). In line with this, emotion regulation might be a key process underlying emotional changes during ImRs [33], probably leading to the abovementioned affective, cognitive, and physiological effects of ImRs. Autonomic responses (e.g., HR, HRV) during ImRs as indicators of underlying emotional and regulatory processes (e.g., initial activation of the aversive memory during reexperiencing, emotion regulation during rescripting) have, however, not been examined in patients with SAD so far.

The current study aimed to fill this gap by investigating physiological correlates (HR, HRV) as well as changes in self-reported positive and negative feelings in the course of one session of ImRs compared to a verbally-based control intervention in patients with SAD. We hypothesized a larger increase in negative feelings/decrease in positive feelings during reexperiencing (baseline – phase 1), as well as a larger decrease in negative/increase in positive feelings in response to the actual rescripting phases (phase 1 – phase 2, phase 2 – phase 3) for ImRs compared to the control intervention. On the physiological level, ImRs is expected to result in higher mean HR/reduced HRV (RMSSD) during reexperiencing of the aversive memory in phase 1, as well as higher HRV (RMSSD) during phase 2 and phase 3 (each compared to baseline and the control intervention), indicating more adaptive emotion regulation and parasympathetic modulation of autonomic arousal.

Participants

Seventy-seven patients with SAD recruited through the local university (outpatient clinic, postings) were randomly assigned to ImRs (n = 38) and the control intervention (n = 39; matched for sex and SAD symptom severity by a predetermined table, see online Supplement A; for all online suppl. material, see https://doi.org/10.1159/000539402). Participants were blind to treatment assignment. Baseline demographics and clinical characteristics did not differ significantly between groups (see Table 1). A priori power analysis revealed a sample size of 54 participants to be sufficient to detect significant within-between interactions at power of 0.95 and medium effect sizes (G*Power, Version 3.1.9.2) [34]. All participants exceeded cutoff values in the clinician-rated version of the Liebowitz Social Anxiety Scale (LSAS) [35, 36] and the Social Phobia Inventory (SPIN) [37, 38] and fulfilled the DSM-5 criteria for a primary diagnosis of SAD according to a structured diagnostic interview (see online Supplement B). The trial was preregistered at the German Clinical Trial Register (DRKS00016729).

Table 1.

Baseline demographics and clinical characteristics

VariableImRs groupControl groupTest statistics
MSDMSDtdfp
Age 25.00 5.70 26.53 6.61 1.01 66 0.314 
Social anxiety (LSAS) 66.22 23.30 62.66 18.97 −0.69 65 0.493 
Depressive symptoms (BDI-II) 12.48 7.25 12.57 8.87 0.04 62 0.966 
VariableImRs groupControl groupTest statistics
MSDMSDtdfp
Age 25.00 5.70 26.53 6.61 1.01 66 0.314 
Social anxiety (LSAS) 66.22 23.30 62.66 18.97 −0.69 65 0.493 
Depressive symptoms (BDI-II) 12.48 7.25 12.57 8.87 0.04 62 0.966 
n%n%χ2dfp
Sex 
 Female 26 81.25 28 77.78 0.13 0.724 
 Male 18.75 22.22    
Education level 
 Less than high school 2.78 1.50 0.472 
 High school 22 68.75 27 75.00    
 College degree 10 31.25 22.22    
n%n%χ2dfp
Sex 
 Female 26 81.25 28 77.78 0.13 0.724 
 Male 18.75 22.22    
Education level 
 Less than high school 2.78 1.50 0.472 
 High school 22 68.75 27 75.00    
 College degree 10 31.25 22.22    

ImRs, imagery rescripting; LSAS, Liebowitz Social Anxiety Scale; BDI-II, Beck Depression Inventory-II.

Procedure

On the first day, diagnostic interviews and questionnaires were conducted to assess study eligibility. In addition, the aversive social memory targeted by the interventions was selected (see online Supplement C). On the second day (9 to 23 days later), a 5-min baseline measurement was conducted. Immediately afterward, participants received either one session of ImRs or a control intervention. Participants rated the intensity of positive and negative feelings after baseline and during each of the three intervention phases directly after each phase, and electrocardiogram (ECG) was measured throughout the interventions. This study was part of a larger project with additional measures and three additional days (not including further psychotherapeutic interventions, see online Supplement D).

Experimental Interventions

Imagery Rescripting (Duration 20–30 min)

The protocol was subdivided into three phases [5, 6]. During phase 1, participants reexperienced their aversive social memory from their former perspective. In phase 2, participants imagined the same event from an observer’s perspective as their adult self. They were encouraged to carry out changes to the situation to support their former selves. The procedure was repeated if participants did not experience a decrease in negative feelings or if they were not satisfied with the new ending of the situation. During phase 3, participants were again asked to reexperience the event from their former perspective, but with all the changes introduced by the adult self in phase 2.

Control Intervention (Duration 20–30 min)

The control intervention was adapted from the ImRs protocol and consisted of three questions concerning the aversive social memory (see [39]). First, participants were asked to recall every detail regarding the aversive social event in general, second, regarding the location where the event took place, and third, regarding the persons involved in the event. During each phase, they were asked to write down what they remembered regarding the respective question while the experimenter left the room for 3 min. After that, the answers were discussed with the experimenter.

Measures

Self-Reported Feelings

After each phase, participants rated the intensity of positive and negative feelings they experienced at the moment after baseline and during each of the three intervention phases on 9-point scales from 0 (“not at all”) to 8 (“very strong”).

Heart Rate/Heart Rate Variability

The ECG was recorded throughout the baseline measurement, as well as the experimental interventions. For details regarding ECG recording and analyses, see online Supplement E. In addition to mean HR as an indicator for sympathetic/parasympathetic activity, root mean square of successive differences (RMSSD) was selected as the HRV measure and most likely reflects parasympathetic activity (for further parameters, see online suppl. Table 1).

Statistical Analyses

Statistical analyses were conducted by means of IBM SPSS Statistics, version 24. The level of significance was determined at α = 0.05 (two-tailed). Shapiro-Wilk test revealed a violation of normal distribution for self-reported feelings, HR and HRV data, which is why non-parametric testing was applied. Therefore, difference scores between each successive pair of phases for self-reported feelings (phase 1 – baseline, phase 2 – phase 1, phase 3 – phase 2), as well as for each phase compared to baseline (phase 1 – baseline, phase 2 – baseline, phase 3 – baseline) for HR and HRV were computed. Differences between the intervention groups for these difference scores, as well as separately for each phase (follow-up tests), were analyzed by means of Mann-Whitney U tests. Follow-up Wilcoxon signed-rank tests were applied to compare differences between phases within groups.

Self-Reported Feelings

Results (see Table 2, Fig. 1, online suppl. Table 2) showed a larger increase in negative feelings from baseline to phase 1 in the ImRs compared to the control intervention group, as well as for both groups separately. The groups did not differ significantly in negative feelings during baseline and phase 1.

Table 2.

Tests of changes in negative/positive feelings during baseline and the three phases of the interventions (successive pairs), as well as in HRV and HR (natural logarithm) during each phase compared to baseline for ImRs compared to the control intervention, as well as for ImRs and the control intervention, respectively

ImRs versus control interventionImRsControl intervention
UpM diffZpM diffZp
Negative feelings 
 Phase 1 – baseline 404.50 0.032 3.59 −4.97 <0.001 2.61 −4.89 <0.001 
 Phase 2 – phase 1 405.50 0.034 −2.53 −4.44 <0.001 −1.72 4.40 <0.001 
 Phase 3 – phase 2 323.50 0.001 −0.13 −0.04 0.968 1.11 −3.82 <0.001 
Positive feelings 
 Phase 1 – baseline 537.00 0.626       
 Phase 2 – phase 1 239.50 <0.001 3.31 −4.85 <0.001 1.22 −3.58 <0.001 
 Phase 3 – phase 2 393.50 0.034 0.03 −0.27 0.787 −0.75 −2.27 0.023 
HR (mean) 
 Phase 1 – baseline 374.00 0.013 0.11 −4.92 <0.001 0.07 −4.90 <0.001 
 Phase 2 – baseline 465.00 0.173       
 Phase 3 – baseline 573.00 0.971       
HRV (RMSSD) 
 Phase 1 – baseline 479.00 0.233       
 Phase 2 – baseline 435.00 0.083       
 Phase 3 – baseline 407.00 0.038 0.13 −2.21 0.027 0.01 −0.50 0.615 
ImRs versus control interventionImRsControl intervention
UpM diffZpM diffZp
Negative feelings 
 Phase 1 – baseline 404.50 0.032 3.59 −4.97 <0.001 2.61 −4.89 <0.001 
 Phase 2 – phase 1 405.50 0.034 −2.53 −4.44 <0.001 −1.72 4.40 <0.001 
 Phase 3 – phase 2 323.50 0.001 −0.13 −0.04 0.968 1.11 −3.82 <0.001 
Positive feelings 
 Phase 1 – baseline 537.00 0.626       
 Phase 2 – phase 1 239.50 <0.001 3.31 −4.85 <0.001 1.22 −3.58 <0.001 
 Phase 3 – phase 2 393.50 0.034 0.03 −0.27 0.787 −0.75 −2.27 0.023 
HR (mean) 
 Phase 1 – baseline 374.00 0.013 0.11 −4.92 <0.001 0.07 −4.90 <0.001 
 Phase 2 – baseline 465.00 0.173       
 Phase 3 – baseline 573.00 0.971       
HRV (RMSSD) 
 Phase 1 – baseline 479.00 0.233       
 Phase 2 – baseline 435.00 0.083       
 Phase 3 – baseline 407.00 0.038 0.13 −2.21 0.027 0.01 −0.50 0.615 

ImRs, imagery rescripting; HR, heart rate; HRV, heart rate variability; RMSSD, root mean square of successive differences.

Fig. 1.

Self-reported negative (a) and positive (b) feelings after baseline and during each of the three phases of imagery rescripting (ImRs) and the control intervention, as well as heart rate (HR, natural logarithm) (c) and heart rate variability (HRV; root mean square of successive differences [RMSSD], natural logarithm) (d) during each of the three phases compared to baseline.

Fig. 1.

Self-reported negative (a) and positive (b) feelings after baseline and during each of the three phases of imagery rescripting (ImRs) and the control intervention, as well as heart rate (HR, natural logarithm) (c) and heart rate variability (HRV; root mean square of successive differences [RMSSD], natural logarithm) (d) during each of the three phases compared to baseline.

Close modal

From phase 1 to phase 2 of ImRs, negative feelings more strongly decreased and positive feelings more strongly increased compared to the control intervention. These changes were also evident in both groups separately. Moreover, the groups did not differ significantly in negative feelings during phase 2, but ImRs compared to the control intervention resulted in stronger positive feelings during phase 2, but not during phase 1.

The interventions also differed regarding changes in self-reported feelings from phase 2 to phase 3: while no significant changes in self-reported feelings were found from phase 2 to phase 3 of ImRs, the control intervention resulted in an increase in negative feelings and a decrease in positive feelings. Moreover, ImRs compared to the control intervention resulted in lower negative feelings and stronger positive feelings during phase 3.

Mean Heart Rate

Analyses revealed an increased HR during phase 1 compared to baseline for ImRs compared to the control intervention, as well as within the ImRs and the control intervention group, respectively (see Table 2, Fig. 1). The groups, however, did not differ significantly in HR during baseline and phase 1 (see online suppl. Table 2). Furthermore, there were no significant group differences in HR for phases 2 and 3, each compared to baseline.

Heart Rate Variability (RMSSD)

ImRs compared to the control intervention was associated with higher HRV during phase 3 (but not during phases 1 and 2) compared to baseline (see Table 2, Fig. 1). Moreover, HRV was higher for phase 3 versus baseline within the ImRs but not within the control intervention group. However, HRV did not differ significantly between groups during baseline and phase 3, respectively (see online suppl. Table 2).

ImRs is a promising intervention in the treatment of SAD [40], leading to prominent changes in affective, cognitive, and physiological responses toward the aversive memory and/or stressful social situations [10, 13, 41]. Extending these previous findings, the results of the current study demonstrate a specific pattern of affective and physiological responses unfolding during ImRs compared to a verbally-based control intervention. Increased HR and negative feelings during reexperiencing (phase 1 compared to baseline) might represent an activation of the fear structure associated with the aversive memory, which is postulated to be a necessary condition for emotional change [18]. Subsequently, ImRs resulted in a significant decrease in negative and increase in positive feelings from phase 1 to phase 2, replicating previous findings [31]. Extending these findings, affective changes were significantly larger (phase 1 vs. phase 2) and more stable (phase 2 vs. phase 3) compared to a verbally-based control intervention. Moreover, phase 3, compared to baseline, was associated with higher HRV (RMSSD) in the ImRs compared to the control intervention group. This finding aligns with a previous study that reported increased HRV during a speech task after a single group session of ImRs, indicating enhanced parasympathetically mediated control over physiological responses as a result of ImRs [20]. As HRV has previously been associated with emotion regulation processes [24, 42, 43], a larger increase in HRV during phase 3 might point to regulatory processes taking place during the intervention (e.g., reappraisal [33]), probably leading to the abovementioned alterations in positive and negative feelings. This might be related to the theorized modification of the original or the creation of a new representation of the aversive event in memory and associated changes in the meaning of the memory [4, 7, 8, 18], which has to be investigated in future studies.

Despite these new and promising findings, the current study has some limitations. Competing processes taking place within each phase of the intervention (e.g., emotional activation and regulation) might contribute to nonsignificant differences in physiological measures between ImRs and the control intervention, e.g., regarding HRV during phase 2 (vs. baseline). Furthermore, we used a novel control intervention that has only been tested in HC so far [39]. In addition, our study investigated an unrepresentative sample (higher level of education), as well as the implementation of a single session of ImRs under laboratory conditions (not in routine care).

It nevertheless provides new insights into the potential relevance of psychophysiological biomarkers to investigate change processes during psychotherapeutic interventions such as ImRs. Understanding the underlying processes might further improve the effect of the intervention by identifying novel potential treatment targets that target physiological processes and positive feelings.

This study protocol was reviewed and approved by the Local Ethics Committee of the Faculty of Psychology and Sport Science at the Justus Liebig University Giessen, 2018-0036. Written informed consent was obtained from all participants.

The authors have no conflicts of interest to declare.

This work was supported by a PhD scholarship of the Verhaltenstherapeutische Ambulanz to R.J. Seinsche, Justus Liebig University Giessen. The study was further supported by grants from the German Research Foundation (DFG) to A. Hermann (HE 7013/2-1), and R. Stark (STA 475/20-1) and by “The Adaptive Mind,” funded by the Excellence Program of the Hessian Ministry of Higher Education, Science, Research and the Arts. The Verhaltenstherapeutische Ambulanz, DFG, and Hessian Ministry of Higher Education, Science, Research and the Arts had no further role in study design, collection, analysis, and interpretation of data, in the writing of the manuscript, or in the decision to submit the paper for publication.

Rosa J. Seinsche: conceptualization, methodology, formal analysis, investigation, and writing – original draft. Susanne Fricke: conceptualization, investigation, and writing – review and editing. Marie K. Neudert and Raphaela I. Zimmer: conceptualization and writing – review and editing. Rudolf Stark: supervision, funding acquisition, and writing – review and editing. Andrea Hermann: conceptualization, methodology, formal analysis, supervision, funding acquisition, resources, and writing – review and editing.

The data that support the findings of this study are not publicly available as they contain information that could compromise the privacy of research participants but are available from the corresponding author (A.H.) upon reasonable request.

1.
Wild
J
,
Hackmann
A
,
Clark
DM
.
When the present visits the past: updating traumatic memories in social phobia
.
J Behav Ther Exp Psychiatry
.
2007
;
38
(
4
):
386
401
.
2.
Norton
AR
,
Abbott
MJ
.
Bridging the gap between aetiological and maintaining factors in social anxiety disorder: the impact of socially traumatic experiences on beliefs, imagery and symptomatology
.
Clin Psychol Psychother
.
2017
;
24
(
3
):
747
65
.
3.
Norton
AR
,
Abbott
MJ
.
The role of environmental factors in the aetiology of social anxiety disorder: a review of the theoretical and empirical literature
.
Behav Change
.
2017
;
34
(
2
):
76
97
.
4.
Arntz
A
.
Imagery rescripting as a therapeutic technique: review of clinical trials, basic studies, and research agenda
.
J Exp Psychopathology
.
2012
;
3
(
2
):
189
208
.
5.
Arntz
A
,
Weertman
A
.
Treatment of childhood memories: theory and practice
.
Behav Res Ther
.
1999
;
37
(
8
):
715
40
.
6.
Wild
J
,
Clark
DM
.
Imagery rescripting of early traumatic memories in social phobia
.
Cogn Behav Pract
.
2011
;
18
(
4
):
433
43
.
7.
Strachan
LP
,
Hyett
MP
,
McEvoy
PM
.
Imagery rescripting for anxiety disorders and obsessive-compulsive disorder: recent advances and future directions
.
8.
Brewin
CR
,
Gregory
JD
,
Lipton
M
,
Burgess
N
.
Intrusive images in psychological disorders: characteristics, neural mechanisms, and treatment implications
.
Psychol Rev
.
2010
;
117
(
1
):
210
32
.
9.
Kunze
AE
,
Arntz
A
,
Kindt
M
.
Investigating the effects of imagery rescripting on emotional memory: a series of analogue studies
.
J Exp Psychopathol
.
2019
;
10
(
2
):
204380871985073
.
10.
Romano
M
,
Moscovitch
DA
,
Huppert
JD
,
Reimer
SG
,
Moscovitch
M
.
The effects of imagery rescripting on memory outcomes in social anxiety disorder
.
J Anxiety Disord
.
2020
;
69
:
102169
.
11.
Knutsson
J
,
Nilsson
J-E
,
Eriksson
Å
,
Järild
L
.
Imagery rescripting and exposure in social anxiety: a randomized trial comparing treatment techniques
.
J Contemp Psychother
.
2020
;
50
(
3
):
233
40
.
12.
Wild
J
,
Hackmann
A
,
Clark
DM
.
Rescripting early memories linked to negative images in social phobia: a pilot study
.
Behav Ther
.
2008
;
39
(
1
):
47
56
.
13.
Reimer
SG
,
Moscovitch
DA
.
The impact of imagery rescripting on memory appraisals and core beliefs in social anxiety disorder
.
Behav Res Ther
.
2015
;
75
:
48
59
.
14.
Norton
AR
,
Abbott
MJ
.
The efficacy of imagery rescripting compared to cognitive restructuring for social anxiety disorder
.
J Anxiety Disord
.
2016
;
40
:
18
28
.
15.
Siegesleitner
M
,
Strohm
M
,
Wittekind
CE
,
Ehring
T
,
Kunze
AE
.
Effects of imagery rescripting on consolidated memories of an aversive film
.
J Behav Ther Exp Psychiatry
.
2019
;
62
:
22
9
.
16.
Strohm
M
,
Siegesleitner
M
,
Kunze
AE
,
Ehring
T
,
Wittekind
CE
.
Imagery rescripting of aversive autobiographical memories: effects on memory distress, emotions, and feelings of mastery
.
Cogn Ther Res
.
2019
;
43
(
6
):
1005
17
.
17.
Holmes
EA
,
Mathews
A
.
Mental imagery in emotion and emotional disorders
.
Clin Psychol Rev
.
2010
;
30
(
3
):
349
62
.
18.
Foa
EB
,
Kozak
MJ
.
Emotional processing of fear: exposure to corrective information
.
Psychol Bull
.
1986
;
99
(
1
):
20
35
.
19.
McEvoy
PM
,
Hyett
MP
,
Johnson
AR
,
Erceg-Hurn
DM
,
Clarke
PJF
,
Kyron
MJ
, et al
.
Impacts of imagery-enhanced versus verbally-based cognitive behavioral group therapy on psychophysiological parameters in social anxiety disorder: results from a randomized-controlled trial
.
Behav Res Ther
.
2022
;
155
:
104131
.
20.
Hyett
MP
,
Bank
SR
,
Lipp
OV
,
Erceg-Hurn
DM
,
Alvares
GA
,
Maclaine
E
, et al
.
Attenuated psychophysiological reactivity following single-session group imagery rescripting versus verbal restructuring in social anxiety disorder: results from a randomized controlled trial
.
Psychother Psychosom
.
2018
;
87
(
6
):
340
9
.
21.
Porges
SW
.
Emotion: an evolutionary by-product of the neural regulation of the autonomic nervous system
.
Ann N Y Acad Sci
.
1997
;
807
:
62
77
.
22.
Thayer
JF
,
Ahs
F
,
Fredrikson
M
,
Sollers
JJ
,
Wager
TD
.
A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health
.
Neurosci Biobehav Rev
.
2012
;
36
(
2
):
747
56
.
23.
Laborde
S
,
Mosley
E
,
Thayer
JF
.
Heart rate variability and cardiac vagal tone in psychophysiological research: recommendations for experiment planning, data analysis, and data reporting
.
Front Psychol
.
2017
;
8
:
213
.
24.
Butler
EA
,
Wilhelm
FH
,
Gross
JJ
.
Respiratory sinus arrhythmia, emotion, and emotion regulation during social interaction
.
Psychophysiology
.
2006
;
43
(
6
):
612
22
.
25.
Lane
RD
,
McRae
K
,
Reiman
EM
,
Chen
K
,
Ahern
GL
,
Thayer
JF
.
Neural correlates of heart rate variability during emotion
.
Neuroimage
.
2009
;
44
(
1
):
213
22
.
26.
Seinsche
RJ
,
Fricke
S
,
Neudert
MK
,
Zehtner
RI
,
Walter
B
,
Stark
R
, et al
.
Memory representation of aversive social experiences in Social Anxiety Disorder
.
J Anxiety Disord
.
2023
;
94
:
102669
.
27.
Sansen
LM
,
Iffland
B
,
Neuner
F
.
The trauma of peer victimization: psychophysiological and emotional characteristics of memory imagery in subjects with social anxiety disorder
.
Psychophysiology
.
2015
;
52
(
1
):
107
16
.
28.
McTeague
LM
,
Lang
PJ
,
Laplante
MC
,
Cuthbert
BN
,
Strauss
CC
,
Bradley
MM
.
Fearful imagery in social phobia: generalization, comorbidity, and physiological reactivity
.
Biol Psychiatry
.
2009
;
65
(
5
):
374
82
.
29.
Kreibig
SD
.
Autonomic nervous system activity in emotion: a review
.
Biol Psychol
.
2010
;
84
(
3
):
394
421
.
30.
Mauss
IB
,
Robinson
MD
.
Measures of emotion: a review
.
Cogn Emot
.
2009
;
23
(
2
):
209
37
.
31.
McCarthy
A
,
Bank
SR
,
Campbell
BNC
,
Summers
M
,
Burgess
M
,
McEvoy
P
.
An investigation of cognitive and affective changes during group imagery rescripting for social anxiety disorder
.
Behav Ther
.
2022
;
53
(
5
):
1050
61
.
32.
Gross
JJ
.
The emerging field of emotion regulation: an integrative review
.
Rev Gen Psychol
.
1998
;
2
(
3
):
271
99
.
33.
Fassbinder
E
,
Schweiger
U
,
Martius
D
,
Brand-de Wilde
O
,
Arntz
A
.
Emotion regulation in schema therapy and dialectical behavior therapy
.
Front Psychol
.
2016
;
7
:
1373
.
34.
Faul
F
,
Erdfelder
E
,
Lang
A-G
,
Buchner
A
.
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences
.
Behav Res Methods
.
2007
;
39
(
2
):
175
91
.
35.
Liebowitz
MR
.
Social phobia
.
Mod Probl Pharmacopsychiatry
.
1987
;
22
:
141
73
.
36.
Consbruch
K
,
Stangier
U
,
Heidenreich
T
.
Soziale Angst-Skalen (SOZAS), SIAS SPS, SPIN LSAS
.
Göttingen
:
Hogrefe
;
2016
.
37.
Connor
KM
,
Davidson
JR
,
Churchill
LE
,
Sherwood
A
,
Foa
E
,
Weisler
RH
.
Psychometric properties of the social phobia inventory (SPIN). New self-rating scale
.
Br J Psychiatry
.
2000
;
176
:
379
86
.
38.
Sosic
Z
,
Gieler
U
,
Stangier
U
.
Screening for social phobia in medical in- and outpatients with the German version of the Social Phobia Inventory (SPIN)
.
J Anxiety Disord
.
2008
;
22
(
5
):
849
59
.
39.
Seinsche
RJ
,
Fricke
S
,
Schäfer
A
,
Neudert
MK
,
Zehtner
RI
,
Stark
R
, et al
.
Effects of imagery rescripting on emotional responses during imagination of a socially aversive experience
.
J Emotion Psychopathol
.
2023
;
1
:
113
28
.
40.
Lloyd
J
,
Marczak
M
.
Imagery rescripting and negative self-imagery in social anxiety disorder: a systematic literature review
.
Behav Cogn Psychother
.
2022
;
50
(
3
):
280
97
.
41.
Lee
SW
,
Kwon
JH
.
The efficacy of imagery rescripting (IR) for social phobia: a randomized controlled trial
.
J Behav Ther Exp Psychiatry
.
2013
;
44
(
4
):
351
60
.
42.
Appelhans
BM
,
Luecken
LJ
.
Heart rate variability as an index of regulated emotional responding
.
Rev Gen Psychol
.
2006
;
10
(
3
):
229
40
.
43.
Thayer
JF
,
Lane
RD
.
A model of neurovisceral integration in emotion regulation and dysregulation
.
J Affect Disord
.
2000
;
61
(
3
):
201
16
.